# A Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Profile of TNM005 in Healthy Adult Subjectsy

> **NCT06068608** · PHASE1 · UNKNOWN · sponsor: **Zhuhai Trinomab Pharmaceutical Co., Ltd.** · enrollment: 48 (estimated)

## Conditions studied

- Varicella

## Interventions

- **DRUG:** TNM005
- **DRUG:** Placebo
- **DRUG:** VariZIG

## Key facts

- **NCT ID:** NCT06068608
- **Lead sponsor:** Zhuhai Trinomab Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-12
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2024-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06068608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06068608, "A Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Profile of TNM005 in Healthy Adult Subjectsy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06068608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*